|
1
|
Wang XF, Xing ML, Shen Y, Zhu X and Xu LH:
Oral administration of Cr(VI) induced oxidative stress, DNA damage
and apoptotic cell death in mice. Toxicology. 228:16–23. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun H, Brocato J and Costa M: Oral
chromium exposure and toxicity. Curr Environ Health Rep. 2:295–303.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Izbicki JA, Wright MT, Seymour WA,
BlaineMcCleskey R, Fram MS, Belitz KF and Esser BK: Cr(VI)
occurrence and geochemistry in water from public-supply wells in
California. Appl Geochem. 63:203–217. 2015. View Article : Google Scholar
|
|
4
|
Chen Y, An D, Sun S, Gao J and Qian L:
Reduction and removal of chromium VI in water by powdered activated
carbon. Materials (Basel). 11(pii): E2692018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiu A, Shi XL, Lee WK, Hill R, Wakeman
TP, Katz A, Xu B, Dalal NS, Robertson JD, Chen C, et al: Review of
chromium (VI) apoptosis, cell-cycle-arrest, and carcinogenesis. J
Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 28:188–230.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu G, Zheng P, Feng H and Jia G: Imbalance
of oxidative and reductive species involved in chromium(VI)-induced
toxic effects. Reactive Oxygen Species. 3:12017.
|
|
7
|
Liu KJ and Shi X: In vivo reduction of
chromium (VI) and its related free radical generation. Mol Cell
Biochem. 222:41–47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan TL, Wang PW, Chen CC, Fang JY and
Sintupisut N: Functional proteomics reveals hepatotoxicity and the
molecular mechanisms of different forms of chromium delivered by
skin administration. Proteomics. 12:477–489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bright P, Burge PS, O'Hickey SP, Gannon
PF, Robertson AS and Boran A: Occupational asthma due to chrome and
nickel electroplating. Thorax. 52:28–32. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costa M: Toxicity and carcinogenicity of
Cr(VI) in animal models and humans. Crit Rev Toxicol. 27:431–442.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Verschoor MA, Bragt PC, Herber RF,
Zielhuis RL and Zwennis WC: Renal function of chrome-plating
workers and welders. Int Arch Occup Environ Health. 60:67–70. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wedeen RP and Qian LF: Chromium-induced
kidney disease. Environ Health Perspect. 92:71–74. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sharma BK, Singhal PC and Chugh KS:
Intravascular haemolysis and acute renal failure following
potassium dichromate poisoning. Postgrad Med J. 54:414–415. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ellis EN, Brouhard BH, Lynch RE, Dawson
EB, Tisdell R, Nichols MM and Ramirez F: Effects of hemodialysis
and dimercaprol in acute dichromate poisoning. J Toxicol Clin
Toxicol. 19:249–258. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leonard SS, Roberts JR, Antonini JM,
Castranova V and Shi X: PbCrO4 mediates cellular responses via
reactive oxygen species. Mol Cell Biochem. 255:171–179. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sinha K, Das J, Pal PB and Sil PC:
Oxidative stress: The mitochondria-dependent and
mitochondria-independent pathways of apoptosis. Arch Toxicol.
87:1157–1180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Quinteros FA, Poliandri AH, Machiavelli
LI, Cabilla JP and Duvilanski BH: In vivo and in vitro effects of
chromium VI on anterior pituitary hormone release and cell
viability. Toxicol Appl Pharmacol. 218:79–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao F, Li Y, Dai L, Deng Y, Zou Y, Li P,
Yang Y and Zhong C: Hexavalent chromium targets mitochondrial
respiratory chain complex I to induce reactive oxygen
species-dependent caspase-3 activation in L-02 hepatocytes. Int J
Mol Med. 30:629–635. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Molina-Jijon E, Tapia E, Zazueta C, El
Hafidi M, Zatarain-Barrón ZL, Hernández-Pando R, Medina-Campos ON,
Zarco-Márquez G, Torres I and Pedraza-Chaverri J: Curcumin prevents
Cr(VI)-induced renal oxidant damage by a mitochondrial pathway.
Free Radic Biol Med. 51:1543–1557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Redza-Dutordoir M and Averill-Bates DA:
Activation of apoptosis signalling pathways by reactive oxygen
species. Biochim Biophys Acta. 1863:2977–2992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin TJ, Huang YL, Chang JS, Liu KT, Yen
MC, Chen FW, Shih YL, Jao JC, Huang PC and Yeh IJ: Optimal dosage
and early intervention of L-ascorbic acid inhibiting
K2Cr2O7-induced renal tubular cell
damage. J Trace Elem Med Biol. 48:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsujimoto Y: Role of Bcl-2 family proteins
in apoptosis: apoptosomes or mitochondria? Genes Cells. 3:697–707.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Snyder RD: Role of active oxygen species
in metal-induced DNA strand breakage in human diploid fibroblasts.
Mutat Res. 193:237–246. 1988.PubMed/NCBI
|
|
25
|
Wakeman TP, Kim WJ, Callens S, Chiu A,
Brown KD and Xu B: The ATM-SMC1 pathway is essential for activation
of the chromium[VI]-induced S-phase checkpoint. Mutat Res.
554:241–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ha L, Ceryak S and Patierno SR: Generation
of S phase-dependent DNA double-strand breaks by Cr(VI) exposure:
Involvement of ATM in Cr(VI) induction of gamma-H2AX.
Carcinogenesis. 25:2265–2274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayashi Y, Kondo T, Zhao QL, Ogawa R, Cui
ZG, Feril LB Jr, Teranishi H and Kasuya M: Signal transduction of
p53-independent apoptotic pathway induced by hexavalent chromium in
U937 cells. Toxicol Appl Pharmacol. 197:96–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hill R, Leidal AM, Madureira PA, Gillis
LD, Cochrane HK, Waisman DM, Chiu A and Lee PW: Hypersensitivity to
chromium-induced DNA damage correlates with constitutive
deregulation of upstream p53 kinases in p21-/-HCT116 colon cancer
cells. DNA Repair (Amst). 7:239–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pagliara V, Saide A, Mitidieri E,
d'Emmanuele di Villa Bianca R, Sorrentino R, Russo G and Russo A:
5-FU targets rpL3 to induce mitochondrial apoptosis via
cystathionine-beta-synthase in colon cancer cells lacking p53.
Oncotarget. 7:50333–50348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Russo A, Saide A, Cagliani R, Cantile M,
Botti G and Russo G: rpL3 promotes the apoptosis of p53 mutated
lung cancer cells by down-regulating CBS and NFκB upon 5-FU
treatment. Sci Rep. 6:383692016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parveen K, Khan MR and Siddiqui WA:
Pycnogenol prevents potassium dichromate K2Cr2O7-induced oxidative
damage and nephrotoxicity in rats. Chem Biol Interact. 181:343–350.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pedersen RS and Morch PT: Chromic acid
poisoning treated with acute hemodialysis. Nephron. 22:592–595.
1978. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
KhanSaif R, Aparna Q, Shahzad S and Haque
F: Chromium induced AKI: Case with protean implications. Annals
Tropical Medicine Public Health. 7:136–138. 2014.
|
|
34
|
Tait SW and Green DR: Caspase-independent
cell death: Leaving the set without the final cut. Oncogene.
27:6452–6461. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ranjan A and Iwakuma T: Non-canonical cell
death induced by p53. Int J Mol Sci. 17(pii): E20682016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eichler T, Ma Q, Kelly C, Mishra J, Parikh
S, Ransom RF, Devarajan P and Smoyer WE: Single and combination
toxic metal exposures induce apoptosis in cultured murine podocytes
exclusively via the extrinsic caspase 8 pathway. Toxicol Sci.
90:392–399. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vargo-Gogola T, Crawford HC, Fingleton B
and Matrisian LM: Identification of novel matrix
metalloproteinase-7 (matrilysin) cleavage sites in murine and human
Fas ligand. Arch Biochem Biophys. 408:155–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Musial K and Zwolinska D: Matrix
metalloproteinases and soluble Fas/FasL system as novel regulators
of apoptosis in children and young adults on chronic dialysis.
Apoptosis. 16:653–659. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cammarota M, Lamberti M, Masella L,
Galletti P, De Rosa M, Sannolo N and Giuliano M: Matrix
metalloproteinases and their inhibitors as biomarkers for metal
toxicity in vitro. Toxicol In Vitro. 20:1125–1132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wan R, Mo Y, Zhang X, Chien S, Tollerud DJ
and Zhang Q: Matrix metalloproteinase-2 and −9 are induced
differently by metal nanoparticles in human monocytes: The role of
oxidative stress and protein tyrosine kinase activation. Toxicol
Appl Pharmacol. 233:276–285. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Blaser H, Dostert C, Mak TW and Brenner D:
TNF and ROS crosstalk in inflammation. Trends Cell Biol.
26:249–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
